1260081-86-4Relevant articles and documents
Pyruvate kinase activators for use in therapy
-
Page/Page column 113, (2016/08/29)
Described herein are methods for using compounds that activate pyruvate kinase.
THERAPEUTIC COMPOUNDS AND COMPOSITIONS
-
Page/Page column 54, (2011/01/05)
Compounds and compositions comprising compounds that modulate pyruvate kinase M2 (PKM2) are described herein. Also described herein are methods of using the compounds that modulate PKM2 in the treatment of cancer.